Company intelligence / Profile preview

MAG & More

Munich, Bavaria, Germany

Ownership: Private
Employees: ~11
Development stage: Other

Overview

MAG & More is a German medical device company focused on transcranial magnetic stimulation (TMS) systems for clinical practice and research. Its product portfolio includes commercial TMS therapy systems, stimulation coils, accessories, and MR-based neuronavigation software used by healthcare providers and neuroscience researchers. The company is best known for Apollo TMS Therapy for depression treatment and the PowerMAG research platform. MAG & More became part of neurocare group in 2021, linking its device business with a broader digital therapeutics and mental health care platform. The company operates as a commercial-stage neurostimulation business rather than a drug developer.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on MAG & More.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAG & More.

Explore the full profile